Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genuity Science was a leading genomics and biological data analytics company specializing in population-scale genomic sequencing, deep phenotyping, and advanced AI/machine learning-driven insights to accelerate precision medicine. The company enabled biopharma partners to identify novel disease targets, optimize portfolios, design better clinical trials through sub-population stratification, and discover biomarkers. It did not develop its own therapeutics but provided critical infrastructure for target discovery and validation across CNS, cardiometabolic, inflammatory disorders, among others. In August 2021 it was acquired by HiberCell.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genuity Science.